<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04540055</url>
  </required_header>
  <id_info>
    <org_study_id>UNUD-CTR-FK300820-004</org_study_id>
    <nct_id>NCT04540055</nct_id>
  </id_info>
  <brief_title>General Anesthesia and Paravertebral Blocks vs. General Anesthesia Only: Influence Inflammation Factors and Clinical Outcomes in Modified Radical Mastectomy</brief_title>
  <official_title>Effects of General Anesthesia vs. General Anesthesia and Paravertebral Block to IL-2, IL-6, PGE2, MMP-9, and Clinical Outcome in Modified Radical Mastectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Udayana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Udayana University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Regional anesthesia and analgesia may maintain immune function, reduce surgical stress, and&#xD;
      also reduce volatile anesthetics and opioids requirements. Local anesthetic drugs used in&#xD;
      regional anesthesia and analgesia work to have anti-proliferative and cytotoxic effects on&#xD;
      cancer cells. Pro-inflammatory cytokines such as IL-1, IL-6, and TNF-alpha increase in levels&#xD;
      in peripheral nerves, spinal cord, brain (brain stem, locus sereleus, thalamus, hippocampus,&#xD;
      and prefrontal cortex) after peripheral nerves are injured. The anti-inflammatory cytokine&#xD;
      IL-10 is decreased in levels after peripheral nerve injury. The balance between&#xD;
      pro-inflammatory and anti-inflammatory cytokines affects the severity of pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Actual">January 21, 2021</completion_date>
  <primary_completion_date type="Actual">December 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of IL-2 in blood serum</measure>
    <time_frame>1-hour after surgery</time_frame>
    <description>Concentration of IL-2 level in blood serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of IL-2 in blood serum</measure>
    <time_frame>24-hours after surgery</time_frame>
    <description>Concentration of IL-2 level in blood serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of IL-6 in blood serum</measure>
    <time_frame>1-hour after surgery</time_frame>
    <description>Concentration of IL-6 level in blood serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of IL-6 in blood serum</measure>
    <time_frame>24-hours after surgery</time_frame>
    <description>Concentration of IL-6 level in blood serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>24-hours after surgery</time_frame>
    <description>pain score measured by visual analog scale (VAS), scaled between 0 (no pain) and 10 (worst pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of PGE2 level in blood serum</measure>
    <time_frame>1-hour after surgery</time_frame>
    <description>Concentration of PGE2 level in blood serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of PGE2 level in blood serum</measure>
    <time_frame>24-hours after surgery</time_frame>
    <description>Concentration of PGE2 level in blood serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of MMP-9 level in blood serum</measure>
    <time_frame>1-hour after surgery</time_frame>
    <description>Concentration of MMP-9 level in blood serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of MMP-9 level in blood serum</measure>
    <time_frame>24-hours after surgery</time_frame>
    <description>Concentration of MMP-9 level in blood serum</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">88</enrollment>
  <condition>Anesthesia, Local</condition>
  <condition>Anesthesia</condition>
  <condition>Inflammatory Response</condition>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Paravertebral (Group P)</arm_group_label>
    <description>Patients underwent MRM under the combination of general anesthesia and paravertebral block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General Anesthesia (Group G)</arm_group_label>
    <description>Patients underwent MRM under general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Paravertebral block</intervention_name>
    <description>The subjects in this group received general anesthesia and USG-guided paravertebral block</description>
    <arm_group_label>Paravertebral (Group P)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General Anesthesia</intervention_name>
    <description>The subjects in this group underwent MRM under routine general anesthesia without peripheral nerve block supplementation.</description>
    <arm_group_label>General Anesthesia (Group G)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with breast cancer (stadium Ia-IIIb) who underwent MRM surgery under general&#xD;
        anesthesia in Sanglah General Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with breast cancer (stadium Ia, Ib, IIa, IIb, IIIa, IIIb) undergoing MRM&#xD;
             surgery&#xD;
&#xD;
          -  Balinese race&#xD;
&#xD;
          -  ASA physical status I, II, III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of allergy to drugs used in anesthesia&#xD;
&#xD;
          -  History psychiatric disorder&#xD;
&#xD;
          -  History of perioperative transfusion&#xD;
&#xD;
          -  History of autoimmune disease&#xD;
&#xD;
          -  History of taking beta blockers or anti-platelet aggregation medications&#xD;
&#xD;
          -  Previous breast surgery&#xD;
&#xD;
          -  Spine deformity&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Local infections in paravertebral block site&#xD;
&#xD;
          -  Decreased renal function&#xD;
&#xD;
          -  Neurological deficits&#xD;
&#xD;
          -  Peptic ulcer&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sanglah General Hospital</name>
      <address>
        <city>Denpasar</city>
        <state>Bali</state>
        <zip>80114</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 31, 2020</study_first_submitted>
  <study_first_submitted_qc>August 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2020</study_first_posted>
  <last_update_submitted>January 20, 2021</last_update_submitted>
  <last_update_submitted_qc>January 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Udayana University</investigator_affiliation>
    <investigator_full_name>Christopher Ryalino</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

